Presentation TVT 2022 Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF? Presenter: Sanjiv Shah June 10, 2022
Presentation TVT 2022 Residual ASD Post-TMVR: Severity Assessment and Indication for Closure Presenter: Torsten P. Vahl June 10, 2022
Presentation TVT 2022 Less Invasive Ventricular Enhancement for HFrEF Presenter: John Boehmer June 10, 2022
Presentation TVT 2022 LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management Presenter: Vinayak N. Bapat June 10, 2022
Presentation TVT 2022 Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment Presenter: Chetan Huded June 10, 2022
Presentation TVT 2022 Patient Selection in TMVR Trials: Where Surgery and Catheter-based Therapies Separate or Overlap Presenter: Eberhard Grube June 10, 2022
Presentation TVT 2022 What (Else) Have We Learned From REDUCE-LAP II? Presenter: Sanjiv Shah June 10, 2022
Presentation TVT 2022 Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices Presenter: Daniel Burkhoff June 10, 2022
Presentation TVT 2022 Myocardial Intramural Remodeling by Transvenous Interstitial teTHer Presenter: Christopher Bruce June 10, 2022